Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
The radiologically isolated syndrome dilemma: just an incidental radiological finding or presymptomatic multiple sclerosis?
[Effect of therapeutic apheresis on the lymphocyte sensitivity to corticosteroids in patients with secondary progressive multiple sclerosis.]
[Therapeutic options for autoimmune encephalomyelitis].
Diagnosing neuromyelitis optica.
Antibodies to aquaporin-1 are not present in neuromyelitis optica.
Krabbe disease: involvement of connexin43 in the apoptotic effects of sphingolipid psychosine on mouse oligodendrocyte precursors.
Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.
p(70S6K1) in the TORC1 Pathway is Essential for the Differentiation of Th17 Cells, but Not Th1, Th2, or Treg Cells in Mice.
Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation.
Transverse myelitis in a patient with primary antiphospholipid syndrome.
Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation.
Multiple sclerosis update.
Management of psoriasis vulgaris and multiple sclerosis with fumaric acid.
The insulin-like growth factor system in multiple sclerosis.
IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.
Dual task cost of cognition is related to fall risk in patients with multiple sclerosis: A prospective study.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Multiple sclerosis and pregnancy: therapeutic considerations.
Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder.
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.
Pages
« first
‹ previous
…
465
466
467
468
469
470
471
472
473
…
next ›
last »